Epidemiology of peritoneal dialysis outcomes

Aminu K Bello, Ikechi G Okpechi, Mohamed A Osman, Yeoungjee Cho, Brett Cullis, Htay Htay, Vivekanand Jha, Muhammad A Makusidi, Mignon McCulloch, Nikhil Shah, Marina Wainstein, David W Johnson, Aminu K Bello, Ikechi G Okpechi, Mohamed A Osman, Yeoungjee Cho, Brett Cullis, Htay Htay, Vivekanand Jha, Muhammad A Makusidi, Mignon McCulloch, Nikhil Shah, Marina Wainstein, David W Johnson

Abstract

Peritoneal dialysis (PD) is an important home-based treatment for kidney failure and accounts for 11% of all dialysis and 9% of all kidney replacement therapy globally. Although PD is available in 81% of countries, this provision ranges from 96% in high-income countries to 32% in low-income countries. Compared with haemodialysis, PD has numerous potential advantages, including a simpler technique, greater feasibility of use in remote communities, generally lower cost, lesser need for trained staff, fewer management challenges during natural disasters, possibly better survival in the first few years, greater ability to travel, fewer dietary restrictions, better preservation of residual kidney function, greater treatment satisfaction, better quality of life, better outcomes following subsequent kidney transplantation, delayed need for vascular access (especially in small children), reduced need for erythropoiesis-stimulating agents, and lower risk of blood-borne virus infections and of SARS-CoV-2 infection. PD outcomes have been improving over time but with great variability, driven by individual and system-level inequities and by centre effects; this variation is exacerbated by a lack of standardized outcome definitions. Potential strategies for outcome improvement include enhanced standardization, monitoring and reporting of PD outcomes, and the implementation of continuous quality improvement programmes and of PD-specific interventions, such as incremental PD, the use of biocompatible PD solutions and remote PD monitoring.

Conflict of interest statement

V.J. has received fees from AstraZeneca, NephroPlus and Zydus Cadilla, and grants from Baxter Healthcare, Biocon and GlaxoSmithKline; all funds are paid to his organization. D.W.J. has received consultancy fees, research grants, speaker’s honoraria and travel sponsorships from Baxter Healthcare and Fresenius Medical Care, consultancy fees from Astra Zeneca, Bayer and AWAK, speaker’s honoraria from ONO and BI & Lilly, and travel sponsorships from Ono and Amgen. A.K.B. has received consultancy fees from Amgen, GlaxoSmithKline, Bayer and Otsuka. The other authors declare no competing interests.

© 2022. Springer Nature Limited.

Figures

Fig. 1. Hierarchy of importance of peritoneal…
Fig. 1. Hierarchy of importance of peritoneal dialysis outcomes to patients, caregivers and clinicians.
The Standardized Outcomes in Nephrology in Peritoneal Dialysis (SONG-PD) initiative identified a hierarchy of PD outcomes according to their level of importance to stakeholder groups. The outcomes in the top tier are critically important to all stakeholder groups, those in the middle tier are critically important to some stakeholder groups and those in the bottom tier are important to some or all stakeholder groups. Adapted with permission from ref., Elsevier.
Fig. 2. Correlates of fatigue in kidney…
Fig. 2. Correlates of fatigue in kidney failure.
The onset of fatigue in patients with kidney failure is multidimensional and multifactorial, with bidirectional and circular associations leading to substantial social, mental and physical disability. CRP, C-reactive protein; Hb, haemoglobin; KRT, kidney replacement therapy. Adapted with permission from Artom et al., Elsevier.

References

    1. Pecoits-Filho R, et al. Capturing and monitoring global differences in untreated and treated end-stage kidney disease, kidney replacement therapy modality, and outcomes. Kidney Int. Suppl. 2020;10:e3–e9. doi: 10.1016/j.kisu.2019.11.001.
    1. Bello AK, et al. Status of care for end stage kidney disease in countries and regions worldwide: international cross sectional survey. BMJ. 2019;367:l5873. doi: 10.1136/bmj.l5873.
    1. Bello AK, et al. Assessment of global kidney health care status. JAMA. 2017;317:1864–1881. doi: 10.1001/jama.2017.4046.
    1. Cho Y, et al. Peritoneal dialysis use and practice patterns: an international survey study. Am. J. Kidney Dis. 2021;77:315–325. doi: 10.1053/j.ajkd.2020.05.032.
    1. Karopadi AN, Mason G, Rettore E, Ronco C. Cost of peritoneal dialysis and haemodialysis across the world. Nephrol. Dial. Transpl. 2013;28:2553–2569. doi: 10.1093/ndt/gft214.
    1. Johnson DW, et al. Renal services disaster planning: lessons learnt from the 2011 Queensland floods and North Queensland cyclone experiences. Nephrology. 2013;18:41–46. doi: 10.1111/nep.12008.
    1. Chang YT, et al. Cost-effectiveness of hemodialysis and peritoneal dialysis: a national cohort study with 14 years follow-up and matched for comorbidities and propensity score. Sci. Rep. 2016;6:30266. doi: 10.1038/srep30266.
    1. Juergensen E, et al. Hemodialysis and peritoneal dialysis: patients’ assessment of their satisfaction with therapy and the impact of the therapy on their lives. Clin. J. Am. Soc. Nephrol. 2006;1:1191–1196. doi: 10.2215/CJN.01220406.
    1. Li PK, Chow KM. Peritoneal dialysis-first policy made successful: perspectives and actions. Am. J. kidney Dis. 2013;62:993–1005. doi: 10.1053/j.ajkd.2013.03.038.
    1. Liu FX, et al. A global overview of the impact of peritoneal dialysis first or favored policies: an opinion. Perit. Dial. Int. 2015;35:406–420. doi: 10.3747/pdi.2013.00204.
    1. Sedor JR, et al. ASN End-Stage Renal Disease Task Force: perspective on prospective payments for renal dialysis facilities. J. Am. Soc. Nephrol. 2010;21:1235–1237. doi: 10.1681/ASN.2010060656.
    1. Tantivess S, Werayingyong P, Chuengsaman P, Teerawattananon Y. Universal coverage of renal dialysis in Thailand: promise, progress, and prospects. BMJ. 2013;346:f462. doi: 10.1136/bmj.f462.
    1. Okpechi, I. G. et al. The case for increased peritoneal dialysis utilization in low- and lower-middle-income countries. Nephrology (2022).
    1. Al Sahlawi M, et al. Variation in peritoneal dialysis-related peritonitis outcomes in the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS) Am. J. Kidney Dis. 2022;79:45–55.e41. doi: 10.1053/j.ajkd.2021.03.022.
    1. Perl, J. et al. Peritoneal dialysis-related infection rates and outcomes: results from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS). Am. J. Kidney Dis. (2020).
    1. Cho Y, Johnson DW. Peritoneal dialysis-related peritonitis: towards improving evidence, practices, and outcomes. Am. J. Kidney Dis. 2014;64:278–289. doi: 10.1053/j.ajkd.2014.02.025.
    1. Manera KE, et al. Scope and heterogeneity of outcomes reported in randomized trials in patients receiving peritoneal dialysis. Clin. Kidney J. 2021;14:1817–1825. doi: 10.1093/ckj/sfaa224.
    1. Manera KE, et al. Standardized Outcomes in Nephrology-Peritoneal Dialysis (SONG-PD): Study Protocol for Establishing a Core Outcome Set in PD. Perit. Dial. Int. 2017;37:639–647. doi: 10.3747/pdi.2017.00022.
    1. Manera KE, et al. Patient and Caregiver Priorities for Outcomes in Peritoneal Dialysis: multinational nominal group technique study. Clin. J. Am. Soc. Nephrol. 2019;14:74–83. doi: 10.2215/CJN.05380518.
    1. Manera KE, et al. An international Delphi survey helped develop consensus-based core outcome domains for trials in peritoneal dialysis. Kidney Int. 2019;96:699–710. doi: 10.1016/j.kint.2019.03.015.
    1. Manera KE, et al. Establishing a core outcome set for peritoneal dialysis: report of the SONG-PD (Standardized Outcomes in Nephrology–Peritoneal Dialysis) Consensus Workshop. Am. J. Kidney Dis. 2020;75:404–412. doi: 10.1053/j.ajkd.2019.09.017.
    1. Tong A, et al. Establishing core outcome domains in hemodialysis: report of the Standardized Outcomes in Nephrology-Hemodialysis (SONG-HD) Consensus Workshop. Am. J. Kidney Dis. 2017;69:97–107. doi: 10.1053/j.ajkd.2016.05.022.
    1. Li PK, et al. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Perit. Dial. Int. 2022;42:110–153. doi: 10.1177/08968608221080586.
    1. Manera KE, et al. Patient-reported outcome measures for life participation in peritoneal dialysis: a systematic review. Nephrol. Dial. Transpl. 2021;36:890–901. doi: 10.1093/ndt/gfaa244.
    1. Elphick E, et al. Outcome measures for technique survival reported in peritoneal dialysis: a systematic review. Perit. Dial. Int. 2021;42:279–287. doi: 10.1177/0896860821989874.
    1. Marshall MR. A systematic review of peritoneal dialysis-related peritonitis rates over time from national or regional population-based registries and databases. Perit. Dial. Int. 2022;42:39–47. doi: 10.1177/0896860821996096.
    1. Okpechi IG, et al. Prevalence of peritonitis and mortality in patients with ESKD treated with chronic peritoneal dialysis in Africa: a systematic review. BMJ Open. 2020;10:e039970. doi: 10.1136/bmjopen-2020-039970.
    1. Sethna CB, et al. Risk factors for and outcomes of catheter-associated peritonitis in children: the SCOPE Collaborative. Clin. J. Am. Soc. Nephrol. 2016;11:1590–1596. doi: 10.2215/CJN.02540316.
    1. Ghali JR, et al. Microbiology and outcomes of peritonitis in Australian peritoneal dialysis patients. Perit. Dial. Int. 2011;31:651–662. doi: 10.3747/pdi.2010.00131.
    1. Mujais, S. Microbiology and outcomes of peritonitis in North America. Kidney Int. Suppl., S55–S62, (2006).
    1. Prasad KN, et al. Microbiology and outcomes of peritonitis in northern India. Perit. Dial. Int. 2014;34:188–194. doi: 10.3747/pdi.2012.00233.
    1. de la Espada Piña V, et al. Two decades of analysis of peritonitis in peritoneal dialysis in Andalusia: Epidemiological, clinical, microbiological and progression aspects. Nefrología. 2021;41:417–425.
    1. Wu H, et al. Changes of antibiotic resistance over time among Escherichia coli peritonitis in Southern China. Perit. Dial. Int. 2022;42:218–222. doi: 10.1177/08968608211045272.
    1. Htay H, et al. Center effects and peritoneal dialysis peritonitis outcomes: analysis of a national registry. Am. J. Kidney Dis. 2018;71:814–821. doi: 10.1053/j.ajkd.2017.10.017.
    1. Wang J, et al. Implementation of a continuous quality improvement program reduces the occurrence of peritonitis in PD. Ren. Fail. 2014;36:1029–1032. doi: 10.3109/0886022X.2014.927771.
    1. Yu Y, et al. Impact of continuous quality improvement initiatives on clinical outcomes in peritoneal dialysis. Perit. Dial. Int. 2014;34(Suppl 2):S43–S48. doi: 10.3747/pdi.2013.00123.
    1. McCulloch MI, Nourse P, Argent AC. Use of locally prepared peritoneal dialysis (PD) fluid for acute PD in children and infants in Africa. Perit. Dialysis Int. 2020;40:441–445. doi: 10.1177/0896860820920132.
    1. Nkoy AB, et al. A promising pediatric peritoneal dialysis experience in a resource-limited setting with the support of saving young lives program. Perit. Dial. Int. 2020;40:504–508. doi: 10.1177/0896860819887286.
    1. Lin J, et al. Prevalence and risk factors of exit-site infection in incident peritoneal dialysis patients. Perit. Dial. Int. 2020;40:164–170. doi: 10.1177/0896860819886965.
    1. United States Renal Data System. 2018 Annual Report: End Stage Renal Disease Ch. 5: Mortality, (2018).
    1. United States Renal Data System. 2020 Annual Report: End Stage Renal Disease Ch. 5: Mortality, (2021).
    1. Li PK, et al. Changes in the worldwide epidemiology of peritoneal dialysis. Nat. Rev. Nephrol. 2017;13:90–103. doi: 10.1038/nrneph.2016.181.
    1. Taji L, et al. COVID-19 in patients undergoing long-term dialysis in Ontario. CMAJ. 2021;193:E278–e284. doi: 10.1503/cmaj.202601.
    1. Weinhandl ED, et al. Initial effects of COVID-19 on patients with ESKD. J. Am. Soc. Nephrol. 2021;32:1444–1453. doi: 10.1681/ASN.2021010009.
    1. Termorshuizen F, et al. Hemodialysis and peritoneal dialysis: comparison of adjusted mortality rates according to the duration of dialysis: analysis of The Netherlands Cooperative Study on the Adequacy of Dialysis 2. J. Am. Soc. Nephrol. 2003;14:2851–2860. doi: 10.1097/01.ASN.0000091585.45723.9E.
    1. Noordzij M, Jager KJ. Survival comparisons between haemodialysis and peritoneal dialysis. Nephrol. Dial. Transpl. 2012;27:3385–3387. doi: 10.1093/ndt/gfs031.
    1. Vonesh EF, Snyder JJ, Foley RN, Collins AJ. The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. Kidney Int. 2004;66:2389–2401. doi: 10.1111/j.1523-1755.2004.66028.x.
    1. Schaubel DE, Blake PG, Fenton SS. Effect of renal center characteristics on mortality and technique failure on peritoneal dialysis. Kidney Int. 2001;60:1517–1524. doi: 10.1046/j.1523-1755.2001.00969.x.
    1. Tamayo Isla RA, et al. Baseline predictors of mortality among predominantly rural-dwelling end-stage renal disease patients on chronic dialysis therapies in Limpopo, South Africa. PLoS One. 2016;11:e0156642. doi: 10.1371/journal.pone.0156642.
    1. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am. J. Kidney Dis. 1998;32:S112–S119. doi: 10.1053/ajkd.1998.v32.pm9820470.
    1. Vareta G, et al. Epidemiology of hypertension among patients on peritoneal dialysis using standardized office and ambulatory blood pressure recordings. Am. J. Nephrol. 2022;53:139–147. doi: 10.1159/000521861.
    1. Henry RM, et al. Mild renal insufficiency is associated with increased cardiovascular mortality: the Hoorn Study. Kidney Int. 2002;62:1402–1407. doi: 10.1111/j.1523-1755.2002.kid571.x.
    1. Kendrick J, Chonchol MB. Nontraditional risk factors for cardiovascular disease in patients with chronic kidney disease. Nat. Clin. Pract. Nephrol. 2008;4:672–681. doi: 10.1038/ncpneph0954.
    1. Hegab Z, Gibbons S, Neyses L, Mamas MA. Role of advanced glycation end products in cardiovascular disease. World J. Cardiol. 2012;4:90–102. doi: 10.4330/wjc.v4.i4.90.
    1. Herzig KA, et al. Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients. J. Am. Soc. Nephrol. 2001;12:814–821. doi: 10.1681/ASN.V124814.
    1. Cho Y, et al. Baseline serum interleukin-6 predicts cardiovascular events in incident peritoneal dialysis patients. Perit. Dial. Int. 2015;35:35–42. doi: 10.3747/pdi.2013.00272.
    1. Hung SC, et al. Volume overload correlates with cardiovascular risk factors in patients with chronic kidney disease. Kidney Int. 2014;85:703–709. doi: 10.1038/ki.2013.336.
    1. Wang AY, et al. ISPD cardiovascular and metabolic guidelines in adult peritoneal dialysis patients part I — assessment and management of various cardiovascular risk factors. Perit. Dial. Int. 2015;35:379–387. doi: 10.3747/pdi.2014.00279.
    1. United States Renal Data System. 2020 Annual Report: End Stage Renal Disease Ch. 8: Cardiovascular disease in patients with ESRD, (2021).
    1. ANZDATA Registry. 44th Report Ch. 3: Mortality in kidney failure with replacement therapy (Australia and New Zealand Dialysis and Transplant Registry, 2021).
    1. Ng MSY, Charu V, Johnson DW, O’Shaughnessy MM, Mallett AJ. National and international kidney failure registries: characteristics, commonalities, and contrasts. Kidney Int. 2022;101:23–35. doi: 10.1016/j.kint.2021.09.024.
    1. Jose MD, et al. Peritoneal dialysis practice in Australia and New Zealand: a call to action. Nephrology. 2011;16:19–29. doi: 10.1111/j.1440-1797.2010.01390.x.
    1. Wu C, et al. Peritoneal dialysis in Sichuan province of China — report from the Chinese National Renal Data System. Ren. Fail. 2018;40:577–582. doi: 10.1080/0886022X.2018.1496933.
    1. Lan PG, et al. Duration of hemodialysis following peritoneal dialysis cessation in Australia and New Zealand: proposal for a standardized definition of technique failure. Perit. Dial. Int. 2016;36:623–630. doi: 10.3747/pdi.2015.00218.
    1. Da Luz LG, Ankawi G, Digvijay K, Rosner MH, Ronco C. Technique failure in peritoneal dialysis: etiologies and risk assessment. Blood Purif. 2021;50:42–49. doi: 10.1159/000508159.
    1. Li PK, et al. ISPD peritonitis recommendations: 2016 update on prevention and treatment. Perit. Dial. Int. 2016;36:481–508. doi: 10.3747/pdi.2016.00078.
    1. Lan PG, Clayton PA, Saunders J, Polkinghorne KR, Snelling PL. Predictors and outcomes of transfers from peritoneal dialysis to hemodialysis. Perit. Dial. Int. 2015;35:306–315. doi: 10.3747/pdi.2013.00030.
    1. Isla RAT, et al. Continuous ambulatory peritoneal dialysis in Limpopo Province, South Africa: predictors of patient and technique survival. Perit. Dial. Int. 2014;34:518–525. doi: 10.3747/pdi.2013.00334.
    1. Boyer A, et al. Trends in peritoneal dialysis technique survival, death, and transfer to hemodialysis: a decade of data from the RDPLF. Am. J. Nephrol. 2021;52:318–327. doi: 10.1159/000515472.
    1. Huisman RM, Nieuwenhuizen MG, Th de Charro F. Patient-related and centre-related factors influencing technique survival of peritoneal dialysis in The Netherlands. Nephrol. Dial. Transpl. 2002;17:1655–1660. doi: 10.1093/ndt/17.9.1655.
    1. Afolalu B, et al. Technique failure and center size in a large cohort of peritoneal dialysis patients in a defined geographic area. Perit. Dial. Int. 2009;29:292–296. doi: 10.1177/089686080902900313.
    1. Yang Y, et al. Predictive value of objective nutritional indexes in technique failure in peritoneal dialysis patients. J. Ren. Nutr. 2021 doi: 10.1053/j.jrn.2021.09.005.
    1. Wang IK, et al. Comparison of patient survival and technique survival between continuous ambulatory peritoneal dialysis and automated peritoneal dialysis. Perit. Dial. Int. 2020;40:563–572. doi: 10.1177/0896860820942987.
    1. Song Q, et al. Assisted peritoneal dialysis: a feasible KRT modality for frail older patients with end-stage kidney disease (ESKD) Sci. Rep. 2021;11:14928. doi: 10.1038/s41598-021-94032-8.
    1. Chen JHC, Johnson DW, Hawley C, Boudville N, Lim WH. Association between causes of peritoneal dialysis technique failure and all-cause mortality. Sci. Rep. 2018;8:3980. doi: 10.1038/s41598-018-22335-4.
    1. Chui BK, et al. Health care costs of peritoneal dialysis technique failure and dialysis modality switching. Am. J. Kidney Dis. 2013;61:104–111. doi: 10.1053/j.ajkd.2012.07.010.
    1. Jiang HJ, et al. COVID-19 in peritoneal dialysis patients. Clin. J. Am. Soc. Nephrol. 2020;16:121–123. doi: 10.2215/CJN.07200520.
    1. Quintaliani G, et al. Exposure to novel coronavirus in patients on renal replacement therapy during the exponential phase of COVID-19 pandemic: survey of the Italian Society of Nephrology. J. Nephrol. 2020;33:725–736. doi: 10.1007/s40620-020-00794-1.
    1. UK Renal Registry. COVID-19 surveillance report for renal centres in the UK: All regions and centres. (2020).
    1. Johnson DW, et al. Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data. Nephrol. Dial. Transpl. 2009;24:1598–1603. doi: 10.1093/ndt/gfn684.
    1. Cendoroglo Neto M, et al. Incidence of and risk factors for hepatitis B virus and hepatitis C virus infection among haemodialysis and CAPD patients: evidence for environmental transmission. Nephrol. Dial. Transpl. 1995;10:240–246.
    1. He F, et al. Pneumonia and mortality risk in continuous ambulatory peritoneal dialysis patients with diabetic nephropathy. PLoS One. 2013;8:e61497. doi: 10.1371/journal.pone.0061497.
    1. Guo H, Liu J, Collins AJ, Foley RN. Pneumonia in incident dialysis patients — the United States Renal Data System. Nephrol. Dial. Transpl. 2008;23:680–686. doi: 10.1093/ndt/gfm474.
    1. Johnson DW, et al. Associations of dialysis modality and infectious mortality in incident dialysis patients in Australia and New Zealand. Am. J. Kidney Dis. 2009;53:290–297. doi: 10.1053/j.ajkd.2008.06.032.
    1. United States Renal Data System. Annual Data Report: End Stage Renal Disease Ch. 5: Hospitalization, (2021).
    1. Kawanishi H, et al. Mortality, hospitalization and transfer to haemodialysis and hybrid therapy, in Japanese peritoneal dialysis patients. Perit. Dial. Int. 2021;42:305–313. doi: 10.1177/08968608211016127.
    1. Laurin LP, et al. Outcomes of infection-related hospitalization according to dialysis modality. Clin. J. Am. Soc. Nephrol. 2015;10:817–824. doi: 10.2215/CJN.09210914.
    1. Brown EA, et al. Length of time on peritoneal dialysis and encapsulating peritoneal sclerosis — position paper for ISPD: 2017 Update. Perit. Dial. Int. 2017;37:362–374. doi: 10.3747/pdi.2017.00018.
    1. Johnson DW, et al. Encapsulating peritoneal sclerosis: incidence, predictors, and outcomes. Kidney Int. 2010;77:904–912. doi: 10.1038/ki.2010.16.
    1. Kawanishi H, et al. Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study. Am. J. Kidney Dis. 2004;44:729–737. doi: 10.1016/S0272-6386(04)00953-9.
    1. Kawanishi H, Shintaku S, Banshodani M, Hashimoto S. Past and present perspectives on encapsulating peritoneal sclerosis. Contrib. Nephrol. 2015;185:87–97. doi: 10.1159/000380973.
    1. Korte MR, et al. Increasing incidence of severe encapsulating peritoneal sclerosis after kidney transplantation. Nephrol. Dial. Transpl. 2007;22:2412–2414. doi: 10.1093/ndt/gfm171.
    1. Singh N, et al. Risk factors associated with peritoneal dialysis catheter survival: a 9-year single-center study in 315 patients. J. Vasc. Access. 2010;11:316–322. doi: 10.5301/JVA.2010.5774.
    1. Moreiras Plaza M, Cuíña L, Goyanes GR, Sobrado JA, Gonzalez L. Mechanical complications in chronic peritoneal dialysis. Clin. Nephrol. 1999;52:124–130.
    1. Leblanc M, Ouimet D, Pichette V. Dialysate leaks in peritoneal dialysis. Semin. Dial. 2001;14:50–54. doi: 10.1046/j.1525-139x.2001.00014.x.
    1. Ye H, et al. Urgent-start peritoneal dialysis for patients with end stage renal disease: a 10-year retrospective study. BMC Nephrol. 2019;20:238. doi: 10.1186/s12882-019-1408-9.
    1. García Ramón R, Carrasco AM. Hydrothorax in peritoneal dialysis. Perit. Dial. Int. 1998;18:5–10. doi: 10.1177/089686089801800101.
    1. Abraham G, Shokker A, Blake P, Oreopoulos D. Massive hydrothorax in patients on peritoneal dialysis: a literature review. Adv. Perit. Dial. Conf. Perit. Dial. 1988;4:121.
    1. Jazayeri-Moghadass BS, Sutherland R, Patel LD, Cebotaru V. Small bowel obstruction with a transition point in a patient on peritoneal dialysis. Case Rep. Nephrol. Dial. 2022;12:6–10. doi: 10.1159/000521350.
    1. Kavanagh NT, Schiller B, Saxena AB, Thomas IC, Kurella Tamura M. Prevalence and correlates of functional dependence among maintenance dialysis patients. Hemodial. Int. 2015;19:593–600. doi: 10.1111/hdi.12286.
    1. Wilson S, et al. Known unknowns: Examining the burden of neurocognitive impairment in the end-stage renal failure population. Nephrology. 2018;23:501–506. doi: 10.1111/nep.13223.
    1. Black N. Patient reported outcome measures could help transform healthcare. BMJ. 2013;346:f167. doi: 10.1136/bmj.f167.
    1. Kalantar-Zadeh K, et al. Living Well With Kidney Disease by Patient and Care-Partner Empowerment: Kidney Health for Everyone Everywhere. Can. J. Kidney Health Dis. 2021;8:2054358121995276. doi: 10.1177/2054358121995276.
    1. Okpechi IG, Nthite T, Swanepoel CR. Health-related quality of life in patients on hemodialysis and peritoneal dialysis. Saudi J. Kidney Dis. Transplant. 2013;24:519. doi: 10.4103/1319-2442.111036.
    1. Purnell TS, et al. Comparison of life participation activities among adults treated by hemodialysis, peritoneal dialysis, and kidney transplantation: a systematic review. Am. J. Kidney Dis. 2013;62:953–973. doi: 10.1053/j.ajkd.2013.03.022.
    1. Molsted S, Prescott L, Heaf J, Eidemak I. Assessment and clinical aspects of health-related quality of life in dialysis patients and patients with chronic kidney disease. Nephron. Clin. Pract. 2007;106:c24–c33. doi: 10.1159/000101481.
    1. Julius M, et al. A comparison of employment rates of patients treated with continuous ambulatory peritoneal dialysis vs in-center hemodialysis (Michigan End-Stage Renal Disease Study) Arch. Intern. Med. 1989;149:839–842. doi: 10.1001/archinte.1989.00390040061012.
    1. Chuasuwan A, Pooripussarakul S, Thakkinstian A, Ingsathit A, Pattanaprateep O. Comparisons of quality of life between patients underwent peritoneal dialysis and hemodialysis: a systematic review and meta-analysis. Health Qual. Life Outcomes. 2020;18:191. doi: 10.1186/s12955-020-01449-2.
    1. Zazzeroni L, Pasquinelli G, Nanni E, Cremonini V, Rubbi I. Comparison of quality of life in patients undergoing hemodialysis and peritoneal dialysis: a systematic review and meta-analysis. Kidney Blood Press. Res. 2017;42:717–727. doi: 10.1159/000484115.
    1. Raoofi S, et al. Hemodialysis and peritoneal dialysis-health-related quality of life: systematic review plus meta-analysis. BMJ Support. Palliat. Care. 2021 doi: 10.1136/bmjspcare-2021-003182.
    1. Ghani Z, Rydell H, Jarl J. The effect of peritoneal dialysis on labor market outcomes compared with institutional hemodialysis. Perit. Dial. Int. 2019;39:59–65. doi: 10.3747/pdi.2017.00236.
    1. Fan L, et al. Burden of kidney disease among patients with peritoneal dialysis versus conventional in-centre haemodialysis: a randomised, non-inferiority trial. Perit. Dial. Int. 2022;42:246–258. doi: 10.1177/08968608221088638.
    1. Bunchman TE, Ballal SH. Treatment of inflow pain by pH adjustment of dialysate in peritoneal dialysis. Perit. Dial. Int. 1991;11:179–180. doi: 10.1177/089686089101100216.
    1. Htay H, et al. Biocompatible dialysis fluids for peritoneal dialysis. Cochrane Database Syst. Rev. 2018;10:CD007554.
    1. Blake PG, Sloand JA, McMurray S, Jain AK, Matthews S. A multicenter survey of why and how tidal peritoneal dialysis (TPD) is being used. Perit. Perit. Dial. Int. 2014;34:458–460. doi: 10.3747/pdi.2013.00314.
    1. Yi C, et al. The incidence of pain and its association with quality of life in patients with peritoneal dialysis. Ren. Fail. 2022;44:724–730. doi: 10.1080/0886022X.2022.2068444.
    1. Zuvela J, et al. Gastrointestinal symptoms in patients receiving dialysis: a systematic review. Nephrology. 2018;23:718–727. doi: 10.1111/nep.13243.
    1. Kosmadakis G, Albaret J, Da Costa Correia E, Somda F, Aguilera D. Constipation in peritoneal dialysis patients. Perit. Perit. Dial. Int. 2019;39:399–404. doi: 10.3747/pdi.2018.00169.
    1. Wu MJ, et al. Colonic transit time in long-term dialysis patients. Am. J. Kidney Dis. 2004;44:322–327. doi: 10.1053/j.ajkd.2004.04.048.
    1. Yi C, Wang X, Ye H, Lin J, Yang X. Patient-reported gastrointestinal symptoms in patients with peritoneal dialysis: the prevalence, influence factors and association with quality of life. BMC Nephrol. 2022;23:99. doi: 10.1186/s12882-022-02723-9.
    1. Dong R, Guo ZY, Ding JR, Zhou YY, Wu H. Gastrointestinal symptoms: a comparison between patients undergoing peritoneal dialysis and hemodialysis. World J. Gastroenterol. 2014;20:11370–11375. doi: 10.3748/wjg.v20.i32.11370.
    1. Salamon K, Woods J, Paul E, Huggins C. Peritoneal dialysis patients have higher prevalence of gastrointestinal symptoms than hemodialysis patients. J. Ren. Nutr. 2013;23:114–118. doi: 10.1053/j.jrn.2012.02.007.
    1. Zheng ZH, et al. Bicarbonate-based peritoneal dialysis solution has less effect on ingestive behavior than lactate-based peritoneal dialysis solution. Perit. Dial. Int. 2009;29:656–663. doi: 10.1177/089686080902900611.
    1. Van V, et al. Influence of dialysate on gastric emptying time in peritoneal dialysis patients. Perit. Dial. Int. 2002;22:32–38. doi: 10.1177/089686080202200106.
    1. Artom M, Moss-Morris R, Caskey F, Chilcot J. Fatigue in advanced kidney disease. Kidney Int. 2014;86:497–505. doi: 10.1038/ki.2014.86.
    1. Yngman-Uhlin P, Kjellsdotter A, Uhlin F, Edéll-Gustafsson U. Sleep quality, fatigue, and health-related quality of life in patients on initial peritoneal dialysis and multiple modalities after two years: a prospective study. Nephrol. Nurs. J. 2019;46:615–649.
    1. Jhamb M, et al. Correlates and outcomes of fatigue among incident dialysis patients. Clin. J. Am. Soc. Nephrol. 2009;4:1779–1786. doi: 10.2215/CJN.00190109.
    1. Ossareh S, et al. Fatigue in chronic peritoneal dialysis patients. Int. Urol. Nephrol. 2003;35:535–541. doi: 10.1023/B:UROL.0000025610.67447.b9.
    1. Maruyama Y, Nakayama M, Ueda A, Miyazaki M, Yokoo T. Comparisons of fatigue between dialysis modalities: A cross-sectional study. PLoS One. 2021;16:e0246890. doi: 10.1371/journal.pone.0246890.
    1. Bonner A, Wellard S, Caltabiano M. The impact of fatigue on daily activity in people with chronic kidney disease. J. Clin. Nurs. 2010;19:3006–3015. doi: 10.1111/j.1365-2702.2010.03381.x.
    1. Bonner A, Wellard S, Caltabiano M. Levels of fatigue in people with ESRD living in far North Queensland. J. Clin. Nurs. 2008;17:90–98.
    1. Chang WK, Hung KY, Huang JW, Wu KD, Tsai TJ. Chronic fatigue in long-term peritoneal dialysis patients. Am. J. Nephrol. 2001;21:479–485. doi: 10.1159/000046652.
    1. Chaudhary K. Peritoneal dialysis drop-out: causes and prevention strategies. Int. J. Nephrol. 2011;2011:434608. doi: 10.4061/2011/434608.
    1. Australian New Zealand Clinical Trials Registry. (2022).
    1. Brown EA, et al. Burden of kidney disease, health-related quality of life, and employment among patients receiving peritoneal dialysis and in-center hemodialysis: findings from the DOPPS Program. Am. J. Kidney Dis. 2021;78:489–500.e1. doi: 10.1053/j.ajkd.2021.02.327.
    1. Bautovich A, Katz I, Smith M, Loo CK, Harvey SB. Depression and chronic kidney disease: a review for clinicians. Aust. N. Z. J. Psychiatry. 2014;48:530–541. doi: 10.1177/0004867414528589.
    1. Hedayati SS, Finkelstein FO. Epidemiology, diagnosis, and management of depression in patients with CKD. Am. J. Kidney Dis. 2009;54:741–752. doi: 10.1053/j.ajkd.2009.05.003.
    1. Mahajan S, et al. Analysis of depression and its effect on outcome among adult Indian peritoneal dialysis patients. Perit. Dial. Int. 2007;27:94–96. doi: 10.1177/089686080702700121.
    1. Mok MMY, et al. A longitudinal study on the prevalence and risk factors for depression and anxiety, quality of life, and clinical outcomes in incident peritoneal dialysis patients. Perit. Dial. Int. 2019;39:74–82. doi: 10.3747/pdi.2017.00168.
    1. Lin J, et al. The negative impact of depressive symptoms on patient and technique survival in peritoneal dialysis: a prospective cohort study. Int. Urol. Nephrol. 2020;52:2393–2401. doi: 10.1007/s11255-020-02593-w.
    1. Goh ZS, Griva K. Anxiety and depression in patients with end-stage renal disease: impact and management challenges — a narrative review. Int. J. Nephrol. Renovasc. Dis. 2018;11:93–102. doi: 10.2147/IJNRD.S126615.
    1. Griva K, et al. Predicting technique and patient survival over 12 months in peritoneal dialysis: the role of anxiety and depression. Int. Urol. Nephrol. 2016;48:791–796. doi: 10.1007/s11255-015-1191-x.
    1. Jacquet S, Trinh E. The potential burden of home dialysis on patients and caregivers: a narrative review. Can. J. Kidney Health Dis. 2019;6:2054358119893335. doi: 10.1177/2054358119893335.
    1. Figueiredo AE, et al. Evaluation of physical symptoms in patients on peritoneal dialysis. Int. J. Nephrol. 2012;2012:305424. doi: 10.1155/2012/305424.
    1. Kobrin SM, Berns JS. Quinine — a tonic too bitter for hemodialysis-associated muscle cramps? Semin. Dial. 2007;20:396–401. doi: 10.1111/j.1525-139X.2007.00330.x.
    1. Takahashi A. The pathophysiology of leg cramping during dialysis and the use of carnitine in its treatment. Physiol. Rep. 2021;9:e15114. doi: 10.14814/phy2.15114.
    1. Tessari G, et al. The impact of pruritus on the quality of life of patients undergoing dialysis: a single centre cohort study. J. Nephrol. 2009;22:241–248.
    1. Min JW, et al. Comparison of uremic pruritus between patients undergoing hemodialysis and peritoneal dialysis. Kidney Res. Clin. Pract. 2016;35:107–113. doi: 10.1016/j.krcp.2016.02.002.
    1. Combs SA, Teixeira JP, Germain MJ. Pruritus in kidney disease. Semin. Nephrol. 2015;35:383–391. doi: 10.1016/j.semnephrol.2015.06.009.
    1. Kim D, Pollock C. Epidemiology and burden of chronic kidney disease-associated pruritus. Clin. Kidney J. 2021;14:i1–i7. doi: 10.1093/ckj/sfab142.
    1. Wu HY, et al. Prognostic importance and determinants of uremic pruritus in patients receiving peritoneal dialysis: a prospective cohort study. PLoS One. 2018;13:e0203474. doi: 10.1371/journal.pone.0203474.
    1. Makar M, Smyth B, Brennan F. Chronic kidney disease-associated pruritus: a review. Kidney Blood Press. Res. 2021;46:659–669. doi: 10.1159/000518391.
    1. Allen RP, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep. Med. 2003;4:101–119. doi: 10.1016/S1389-9457(03)00010-8.
    1. Novak M, Mendelssohn D, Shapiro CM, Mucsi I. Diagnosis and management of sleep apnea syndrome and restless legs syndrome in dialysis patients. Semin. Dial. 2006;19:210–216. doi: 10.1111/j.1525-139X.2006.00157.x.
    1. Kavanagh D, Siddiqui S, Geddes CC. Restless legs syndrome in patients on dialysis. Am. J. Kidney Dis. 2004;43:763–771. doi: 10.1053/j.ajkd.2004.01.007.
    1. Zamponi V, et al. Association between type 1 diabetes and female sexual dysfunction. BMC Women’s Health. 2020;20:73. doi: 10.1186/s12905-020-00939-1.
    1. Navaneethan SD, et al. Prevalence and correlates of self-reported sexual dysfunction in CKD: a meta-analysis of observational studies. Am. J. Kidney Dis. 2010;56:670–685. doi: 10.1053/j.ajkd.2010.06.016.
    1. Guney I, et al. Comparison of effects of automated peritoneal dialysis and continuous ambulatory peritoneal dialysis on health-related quality of life, sleep quality, and depression. Hemodial. Int. 2010;14:515–522. doi: 10.1111/j.1542-4758.2010.00465.x.
    1. Eryavuz N, et al. Comparison of sleep quality between hemodialysis and peritoneal dialysis patients. Int. Urol. Nephrol. 2008;40:785–791. doi: 10.1007/s11255-008-9359-2.
    1. Güney I, et al. Sleep quality and depression in peritoneal dialysis patients. Ren. Fail. 2008;30:1017–1022. doi: 10.1080/08860220802406419.
    1. Masoumi M, Naini AE, Aghaghazvini R, Amra B, Gholamrezaei A. Sleep quality in patients on maintenance hemodialysis and peritoneal dialysis. Int. J. Prev. Med. 2013;4:165–172.
    1. Stepanski E, Faber M, Zorick F, Basner R, Roth T. Sleep disorders in patients on continuous ambulatory peritoneal dialysis. J. Am. Soc. Nephrol. 1995;6:192–197. doi: 10.1681/ASN.V62192.
    1. Yang JY, et al. Quality of sleep and psychosocial factors for patients undergoing peritoneal dialysis. Perit. Dial. Int. 2007;27:675–680. doi: 10.1177/089686080702700614.
    1. Li J, et al. Prevalence and risk factors of sleep disturbance in continuous ambulatory peritoneal dialysis patients in Guangzhou, southern China. Int. Urol. Nephrol. 2012;44:929–936. doi: 10.1007/s11255-011-0060-5.
    1. Buysse DJ, Reynolds CF, 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatr. Res. 1989;28:193–213. doi: 10.1016/0165-1781(89)90047-4.
    1. Fleming TR, DeMets DL. Surrogate end points in clinical trials: are we being misled. Ann. Intern. Med. 1996;125:605–613. doi: 10.7326/0003-4819-125-7-199610010-00011.
    1. Bargman JM, Thorpe KE, Churchill DN. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J. Am. Soc. Nephrol. 2001;12:2158–2162. doi: 10.1681/ASN.V12102158.
    1. Vonesh EF, Snyder JJ, Foley RN, Collins AJ. Mortality studies comparing peritoneal dialysis and hemodialysis: what do they tell us? Kidney Int. 2006;70(Suppl. 103):S3–S11. doi: 10.1038/sj.ki.5001910.
    1. Cho Y, et al. The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients. Kidney Int. 2013;84:969–979. doi: 10.1038/ki.2013.190.
    1. Lee Y, et al. Incremental peritoneal dialysis may be beneficial for preserving residual renal function compared to full-dose peritoneal dialysis. Sci. Rep. 2019;9:10105. doi: 10.1038/s41598-019-46654-2.
    1. Htay H, et al. Predictors of residual renal function decline in peritoneal dialysis patients: the balANZ Trial. Perit. Dial. Int. 2017;37:283–289. doi: 10.3747/pdi.2016.00206.
    1. Ethier I, et al. Rate of decline in residual kidney function pre and post peritoneal dialysis initiation: a post hoc analysis of the IDEAL study. PLoS One. 2020;15:e0242254. doi: 10.1371/journal.pone.0242254.
    1. Woodrow G. Volume status in peritoneal dialysis. Perit. Dial. Int. 2011;31(Suppl 2):S77–S82. doi: 10.3747/pdi.2009.00178.
    1. Van Biesen W, et al. Evolution over time of volume status and PD-related practice patterns in an incident peritoneal dialysis cohort. Clin. J. Am. Soc. Nephrol. 2019;14:882–893. doi: 10.2215/CJN.11590918.
    1. Tian N, et al. Bioimpedance guided fluid management in peritoneal dialysis: a randomized controlled trial. Clin. J. Am. Soc. Nephrol. 2020;15:685–694. doi: 10.2215/CJN.06480619.
    1. Brown EA, et al. International Society for Peritoneal Dialysis practice recommendations: prescribing high-quality goal-directed peritoneal dialysis. Perit. Dial. Int. 2020;40:244–253. doi: 10.1177/0896860819895364.
    1. Tan BK, et al. Longitudinal bioimpedance vector plots add little value to fluid management of peritoneal dialysis patients. Kidney Int. 2016;89:487–497. doi: 10.1038/ki.2015.294.
    1. Cocchi R, et al. Prevalence of hypertension in patients on peritoneal dialysis: results of an Italian multicentre study. Nephrol. Dial. Transpl. 1999;14:1536–1540. doi: 10.1093/ndt/14.6.1536.
    1. Koc M, et al. Uncontrolled hypertension due to volume overload contributes to higher left ventricular mass index in CAPD patients. Nephrol. Dial. Transpl. 2002;17:1661–1666. doi: 10.1093/ndt/17.9.1661.
    1. Menon MK, Naimark DM, Bargman JM, Vas SI, Oreopoulos DG. Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function. Nephrol. Dial. Transpl. 2001;16:2207–2213. doi: 10.1093/ndt/16.11.2207.
    1. Jhee JH, et al. The optimal blood pressure target in different dialysis populations. Sci. Rep. 2018;8:14123. doi: 10.1038/s41598-018-32281-w.
    1. Goldfarb-Rumyantzev AS, Baird BC, Leypoldt JK, Cheung AK. The association between BP and mortality in patients on chronic peritoneal dialysis. Nephrol. Dial. Transpl. 2005;20:1693–1701. doi: 10.1093/ndt/gfh856.
    1. Udayaraj UP, et al. Blood pressure and mortality risk on peritoneal dialysis. Am. J. Kidney Dis. 2009;53:70–78. doi: 10.1053/j.ajkd.2008.08.030.
    1. Wang X, Axelsson J, Lindholm B, Wang T. Volume status and blood pressure in continuous ambulatory peritoneal dialysis patients. Blood Purif. 2005;23:373–378. doi: 10.1159/000087194.
    1. Li PK, Chow KM, Wong TY, Leung CB, Szeto CC. Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. A randomized, controlled study. Ann. Intern. Med. 2003;139:105–112. doi: 10.7326/0003-4819-139-2-200307150-00010.
    1. Eckardt K-U, Kasiske BL. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Kidney Int. 2009;76(Suppl. 113):S1–S2. doi: 10.1038/ki.2009.188.
    1. Wang AY. Vascular and other tissue calcification in peritoneal dialysis patients. Perit. Dial. Int. 2009;29(Suppl 2):S9–s14. doi: 10.1177/089686080902902S01.
    1. Levin A, et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int. 2007;71:31–38. doi: 10.1038/sj.ki.5002009.
    1. Tentori F, et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS. Am. J. Kidney Dis. 2008;52:519–530. doi: 10.1053/j.ajkd.2008.03.020.
    1. Nitta K, Hanafusa N, Tsuchiya K. Mineral bone disorders (MBD) in patients on peritoneal dialysis. Ren. Replac. Ther. 2019;5:1–6. doi: 10.1186/s41100-019-0200-4.
    1. Soohoo M, et al. Comparative effectiveness of dialysis modality on laboratory parameters of mineral metabolism. Am. J. Nephrol. 2022;53:157–168. doi: 10.1159/000521508.
    1. Liu CT, et al. Roles of serum calcium, phosphorus, PTH and ALP on mortality in peritoneal dialysis patients: a nationwide, population-based longitudinal study using TWRDS 2005–2012. Sci. Rep. 2017;7:33. doi: 10.1038/s41598-017-00080-4.
    1. Wu M, et al. Associations between serum mineral metabolism parameters and mortality in patients on peritoneal dialysis. Nephrology. 2019;24:1148–1156. doi: 10.1111/nep.13535.
    1. National Kidney Foundation. KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am. J. Kidney. 2006;47:S11–S145.
    1. Wetmore JB, et al. Trends in anemia management practices in patients receiving hemodialysis and peritoneal dialysis: a retrospective cohort analysis. Am. J. Nephrol. 2015;41:354–361. doi: 10.1159/000431335.
    1. Li PKT, et al. Anemia Management in Peritoneal Dialysis: Perspectives From the Asia Pacific Region. Kidney Med. 2021;3:405–411. doi: 10.1016/j.xkme.2021.01.011.
    1. Wu T, et al. Efficacy of roxadustat on anemia and residual renal function in patients new to peritoneal dialysis. Ren. Fail. 2022;44:529–540. doi: 10.1080/0886022X.2022.2050754.
    1. Oveyssi J, et al. Patient and caregiver perspectives on burnout in peritoneal dialysis. Perit. Dial. Int. 2021;41:484–493. doi: 10.1177/0896860820970064.
    1. Dahlerus C, et al. Patient perspectives on the choice of dialysis modality: results from the empowering patients on choices for renal replacement therapy (EPOCH-RRT) Study. Am. J. Kidney Dis. 2016;68:901–910. doi: 10.1053/j.ajkd.2016.05.010.
    1. Brown EA, Dratwa M, Povlsen JV. Assisted peritoneal dialysis-an evolving dialysis modality. Nephrol. Dial. Transpl. 2007;22:3091–3092. doi: 10.1093/ndt/gfm399.
    1. Sukul N, et al. Patient-reported advantages and disadvantages of peritoneal dialysis: results from the PDOPPS. BMC Nephrol. 2019;20:116. doi: 10.1186/s12882-019-1304-3.
    1. Subramanian L, et al. Remote management for peritoneal dialysis: a qualitative study of patient, care partner, and clinician perceptions and priorities in the United States and the United Kingdom. Kidney Med. 2019;1:354–365. doi: 10.1016/j.xkme.2019.07.014.
    1. Vanholder R, et al. Reducing the costs of chronic kidney disease while delivering quality health care: a call to action. Nat. Rev. Nephrol. 2017;13:393–409. doi: 10.1038/nrneph.2017.63.
    1. Liyanage T, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385:1975–1982. doi: 10.1016/S0140-6736(14)61601-9.
    1. Yeung E, et al. Current status of health systems financing and oversight for end-stage kidney disease care: a cross-sectional global survey. BMJ Open. 2021;11:e047245. doi: 10.1136/bmjopen-2020-047245.
    1. Yang F, Liao M, Wang P, Yang Z, Liu Y. The cost-effectiveness of kidney replacement therapy modalities: a systematic review of full economic evaluations. Appl. Health Econ. Health Policy. 2021;19:163–180. doi: 10.1007/s40258-020-00614-4.
    1. Liu J, et al. Financial implications of dialysis modalities in the developing world: s Chinese perspective. Perit. Dial. Int. 2020;40:193–201. doi: 10.1177/0896860819893812.
    1. Schaefer F, Warady BA. Peritoneal dialysis in children with end-stage renal disease. Nat. Rev. Nephrol. 2011;7:659–668. doi: 10.1038/nrneph.2011.135.
    1. Driollet B, et al. Social deprivation is associated with lower access to pre-emptive kidney transplantation and more urgent-start dialysis in the pediatric population. Kidney Int. Rep. 2022;7:741–751. doi: 10.1016/j.ekir.2021.12.015.
    1. Nourse P, et al. ISPD guidelines for peritoneal dialysis in acute kidney injury: 2020 Update (paediatrics) Perit. Dial. Int. 2021;41:139–157. doi: 10.1177/0896860820982120.
    1. Vidal E, et al. Peritoneal dialysis in infants: the experience of the Italian Registry of Paediatric Chronic Dialysis. Nephrol. Dial. Transpl. 2012;27:388–395. doi: 10.1093/ndt/gfr322.
    1. North American Pediatric Renal Trials and Collaborative Studies. 2011 Annual Dialysis Report, (2011).
    1. Carey WA, Martz KL, Warady BA. Outcome of patients initiating chronic peritoneal dialysis during the first year of life. Pediatrics. 2015;136:e615–e622. doi: 10.1542/peds.2015-0980.
    1. Verrina E, et al. A multicenter experience on patient and technique survival in children on chronic dialysis. Pediatr. Nephrol. 2004;19:82–90. doi: 10.1007/s00467-003-1270-6.
    1. Ploos van Amstel S, et al. Mortality in children treated with maintenance peritoneal dialysis: findings from the International Pediatric Peritoneal Dialysis Network Registry. Am. J. Kidney Dis. 2021;78:380–390. doi: 10.1053/j.ajkd.2020.11.031.
    1. Prasad N, et al. Long-term outcomes in children on chronic continuous ambulatory peritoneal dialysis: a retrospective cohort study from a developing country. Pediatr. Nephrol. 2019;34:2389–2397. doi: 10.1007/s00467-019-04311-w.
    1. Bonthuis M, Harambat J, Jager KJ, Vidal E. Growth in children on kidney replacement therapy: a review of data from patient registries. Pediatr. Nephrol. 2021;36:2563–2574. doi: 10.1007/s00467-021-05099-4.
    1. System, U. S. R. D. 2020 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. (National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD).
    1. Ros S, et al. Increased risk of fatal infections in women starting peritoneal dialysis. Perit. Dial. Int. 2013;33:487–494. doi: 10.3747/pdi.2012.00243.
    1. Kotsanas D, Polkinghorne KR, Korman TM, Atkins RC, Brown F. Risk factors for peritoneal dialysis-related peritonitis: can we reduce the incidence and improve patient selection. Nephrology. 2007;12:239–245. doi: 10.1111/j.1440-1797.2006.00756.x.
    1. Kitterer D, Segerer S, Braun N, Alscher MD, Latus J. Gender-specific differences in peritoneal dialysis. Kidney Blood Press. Res. 2017;42:276–283. doi: 10.1159/000477449.
    1. Shen JI, Mitani AA, Saxena AB, Goldstein BA, Winkelmayer WC. Determinants of peritoneal dialysis technique failure in incident US patients. Perit. Dial. Int. 2013;33:155–166. doi: 10.3747/pdi.2011.00233.
    1. Lim WH, Dogra GK, McDonald SP, Brown FG, Johnson DW. Compared with younger peritoneal dialysis patients, elderly patients have similar peritonitis-free survival and lower risk of technique failure, but higher risk of peritonitis-related mortality. Perit. Dial. Int. 2011;31:663–671. doi: 10.3747/pdi.2010.00209.
    1. Mujais S, Story K. Peritoneal dialysis in the US: evaluation of outcomes in contemporary cohorts. Kidney Int. 2006;70(Suppl. 103):S21–S26. doi: 10.1038/sj.ki.5001912.
    1. Yang LY, Thia EW, Tan LK. Obstetric outcomes in women with end-stage renal disease on chronic dialysis: a review. Obstet. Med. 2010;3:48–53. doi: 10.1258/om.2010.100001.
    1. McDonald SP. End-stage kidney disease among indigenous peoples of Australia and New Zealand. Kidney Int. Suppl. 2013;3:170–173. doi: 10.1038/kisup.2013.7.
    1. Tonelli M, et al. Use and outcomes of peritoneal dialysis among Aboriginal people in Canada. J. Am. Soc. Nephrol. 2005;16:482–488. doi: 10.1681/ASN.2004070560.
    1. Prakash S. An international perspective on peritoneal dialysis among indigenous patients. Perit. Dial. Int. 2011;31:390–398. doi: 10.3747/pdi.2010.00228.
    1. Lim WH. Is there a role for peritoneal dialysis in remote aboriginal patients with end-stage renal disease in Australia? Nephrology. 2004;9(Suppl 4):S126–S128. doi: 10.1111/j.1440-1797.2004.00347.x.
    1. Lim WH, Johnson DW, McDonald SP. Higher rate and earlier peritonitis in Aboriginal patients compared to non-Aboriginal patients with end-stage renal failure maintained on peritoneal dialysis in Australia: analysis of ANZDATA. Nephrology. 2005;10:192–197. doi: 10.1111/j.1440-1797.2005.00374.x.
    1. Lim WH, et al. Remote indigenous peritoneal dialysis patients have higher risk of peritonitis, technique failure, all-cause and peritonitis-related mortality. Nephrol. Dial. Transpl. 2011;26:3366–3372. doi: 10.1093/ndt/gfr070.
    1. Ethier I, et al. Dialysis initiation in older persons across centres and over time in Australia and New Zealand. Nephrology. 2021;26:613–622. doi: 10.1111/nep.13873.
    1. Jiang C, Zheng Q. Outcomes of peritoneal dialysis in elderly vs non-elderly patients: A systemic review and meta-analysis. PLoS One. 2022;17:e0263534. doi: 10.1371/journal.pone.0263534.
    1. Iyasere O, et al. Longitudinal trends in quality of life and physical function in frail older dialysis patients: a comparison of assisted peritoneal dialysis and in-center hemodialysis. Perit. Dial. Int. 2019;39:112–118. doi: 10.3747/pdi.2018.00086.
    1. Hofmeister M, Klarenbach S, Soril L, Scott-Douglas N, Clement F. A systematic review and jurisdictional scan of the evidence characterizing and evaluating assisted peritoneal dialysis models. Clin. J. Am. Soc. Nephrol. 2020;15:511–520. doi: 10.2215/CJN.11951019.
    1. Maierean SM, Oliver MJ. Health outcomes and cost considerations of assisted peritoneal dialysis: a narrative review. Blood Purif. 2021;50:662–666. doi: 10.1159/000512839.
    1. Béchade C, et al. Centre characteristics associated with the risk of peritonitis in peritoneal dialysis: a hierarchical modelling approach based on the data of the French Language Peritoneal Dialysis Registry. Nephrol. Dial. Transpl. 2017;32:1018–1023. doi: 10.1093/ndt/gfx051.
    1. Ethier I, et al. Effect of patient- and center-level characteristics on uptake of home dialysis in Australia and New Zealand: a multicenter registry analysis. Nephrol. Dial. Transpl. 2020;35:1938–1949. doi: 10.1093/ndt/gfaa002.
    1. Nadeau-Fredette AC, et al. Center-specific factors associated with peritonitis risk — a multi-center registry analysis. Perit. Dial. Int. 2016;36:509–518. doi: 10.3747/pdi.2015.00146.
    1. Htay H, et al. Multicenter registry analysis of center characteristics associated with technique failure in patients on incident peritoneal dialysis. Clin. J. Am. Soc. Nephrol. 2017;12:1090–1099. doi: 10.2215/CJN.12321216.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa